New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
10:29 EDTAUXLAuxilium generic Testim strategy defended at UBS
UBS believes Auxilium shares are lower as investors assume Upsher’s generic version of Testim could be approved as an AB-rated generic, but the firm noted that is not yet the case. UBS thinks Auxilium shares will recover as investors recognize that the generic strategy should maximize Testim sales over the medium term and maintains its Buy rating and $31 price target on the stock.
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
09:07 EDTAUXLOn The Fly: Pre-market Movers
Subscribe for More Information
07:32 EDTAUXLAuxilium announces positive data from Phase 2a study of CCH with cellulite
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use